Ligand Pharma (LGND) to resume trading at 9:45AM after FDA approval

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI

6. ROST
7. BILL
8. MRNA
9. MRK
10. COTY

November 19, 2012 9:20 AM EST

Price: $287.39 -1.14%

Overall Analyst Rating:
SELL (= Flat)

Ligand Pharmaceuticals (Nasdaq: LGND) to resume trading at 9:45AM ET following FDA approval for PROMACTA

FDA, Trading Halts

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!